Europe — EMA
Palexia (Tapentadol)
Tapentadol, the active ingredient in Palexia, is an opioid analgesic presented as a strength/form for oral use. It is indicated for the management of moderate to severe acute pain in adult patients who require opioid…
International sale not permitted. Listed for the domestic market and B2B only.
Request sourcing
What is Tapentadol?
Tapentadol, the active ingredient in Palexia, is an opioid analgesic presented as a strength/form for oral use. It is indicated for the management of moderate to severe acute pain in adult patients who require opioid therapy. GNH USA supplies Palexia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
GNH USA supplies Palexia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Tapentadol used for?
Tapentadol is an opioid analgesic that is used within the management of pain across several clinical pathways.
- Acute postoperative pain: Provides effective relief of pain following surgical procedures. - Chronic musculoskeletal pain: Helps alleviate persistent pain associated with conditions such as osteoarthritis. - Cancer‑related pain: Contributes to the control of moderate‑to‑high intensity pain in oncology patients. - Neuropathic pain: Offers some benefit in pain arising from nerve damage. - Severe severe pain where other opio ‑
What are the side effects of Tapentadol?
Common
